In December 2010, the US Foods and Drug Administration (FDA) notified its intention to eliminate the breast cancer sign from bevacizumab, saying that it had not been shown to generally be Harmless and successful in breast most cancers individuals.[38][39] The mixed details from four different medical trials confirmed that bevacizumab neither prolon